Discover 443 paid clinical trials in Tucson, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With major studies in this city focused on conditions like Alzheimer's disease, lymphoma, asthma, and various forms of cancer, Tucson offers participants access to innovative care and breakthrough treatments. The city’s strong research network provides opportunities for individuals seeking to explore new treatment options while making a positive impact on medical research and advancements in healthcare.
Filter
2
Filter results
Results: 443
Stress Hydrocortisone In Pediatric Septic Shock
for
Septic Shock
Location: Tucson AZ, Orange CA, Los Angeles CA, Salt Lake City UT,
Sponsor: Jerry Zimmerman
Sex: All
Age: 0 - 17
Code: NCT03401398
Phase 3, Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Tucson AZ, Gilbert AZ, Kingman AZ, Albuquerque NM,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04510597
Phase 3, Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia,
Location: Tucson AZ, Phoenix AZ, Albuquerque NM, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554406
Phase 2, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Tucson AZ, Albuquerque NM, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase 2, Recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: Tucson AZ, Phoenix AZ, Albuquerque NM, Las Vegas NV,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT01790152
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Pharmacogenomics of Warfarin in Hispanics and Latinos
for
Thrombosis, Hemorrhage
Location: Tucson AZ
Sponsor: University of Arizona
Sex: All
Age: 18+
Code: NCT02972385
Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Tucson AZ, Mesa AZ, Phoenix AZ, El Paso TX,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase 3, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Tucson AZ, Albuquerque NM, Rio Rancho NM, Las Vegas NV,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Tucson AZ, Laguna Hills CA, Irvine CA, Costa Mesa CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05633615
Phase 2, Recruiting
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery
for
Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7,
Location: Tucson AZ, Scottsdale AZ, Omaha NE, New Orleans LA,
Sponsor: Academic and Community Cancer Research United
Sex: Female
Age: 18+
Code: NCT04197687
Phase 2, Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Tucson AZ, Albuquerque NM, Los Angeles CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06317649
Phase 2, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Location: Tucson AZ, Mesa AZ, Phoenix AZ, El Paso TX,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT04322318
Phase 2, Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
for
Classic Follicular Lymphoma,
Location: Tucson AZ, Phoenix AZ, Irvine CA, Upland CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06337318
Phase 3, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Tucson AZ, Phoenix AZ, Albuquerque NM, Irvine CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase 2, Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Tucson AZ, Las Cruces NM, Rio Rancho NM, San Diego CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04269902
Phase 3, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Tucson AZ, Albuquerque NM, San Diego CA, San Marcos CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase 2, Phase 3, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Tucson AZ, Phoenix AZ, Rio Rancho NM, Albuquerque NM,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase 2, Phase 3, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study